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Background: African Americans have the highest incidence and mortality and are less likely than whites to have
been screened for colorectal cancer (CRC). Many interventions have been shown to increase CRC screening in
research settings, but few have been evaluated specifically for use in African-American communities in real world
settings. This study aims to identify the most efficacious approach to disseminate an evidence-based intervention in
promoting colorectal screening in African Americans and to identify the factors associated with its efficacy.
Methods/design: In this study, investigators will recruit 20 community coalitions and 7,200 African-Americans age
50 to 74 to test passive and active approaches to disseminating the Educational Program to Increase Colorectal
Cancer Screening (EPICS); to measure the extent to which EPICS is accepted and the fidelity of implementation in
various settings and to estimate the potential translatability and public health impact of EPICS. This four-arm cluster
randomized trial compares the following implementation strategies: passive arms, (web access to facilitator training
materials and toolkits without technical assistance (TA) and (web access, but with technical assistance (TA); active
arms, (in-person access to facilitator training materials and toolkits without TA and (in-person access with TA).
Primary outcome measures are the reach (the proportion of representative community coalitions and individuals
participating) and efficacy (post-intervention changes in CRC screening rates). Secondary outcomes include
adoption (percentage of community coalitions implementing the EPICS sessions) and implementation (quality and
consistency of the intervention delivery). The extent to which community coalitions continue to implement EPICS
post-implementation (maintenance) will also be measured. Cost-effectiveness analysis will be conducted.
Discussion: Implementing EPICS in partnership with community coalitions, we hypothesized, will result in more
rapid adoption than traditional top-down approaches, and resulting changes in community CRC screening
practices are more likely to be sustainable over time. With its national reach, this study has the potential to
enhance our understanding of barriers and enablers to the uptake of educational programs aimed at eliminating
cancer disparities.
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Colorectal cancer (CRC) is the third most commonly diag-
nosed cancer and the second leading cause of cancer death
in the United States (US) [1]. The American Cancer Society
(ACS) estimates that over 142,820 people will be diagnosed
with CRC and over 50,830 people will die from this disease
in 2013 [1]. The most frequently recommended screening
tests for CRC include annual fecal occult blood testing
(FOBT) or colonoscopy every ten years. Alternative screen-
ing tests are sometimes used: sigmoidoscopy every five
years (combined with annual FOBT), or double-contrast
barium enema every five years. Fecal DNA and computed
colonoscopy are available, but still considered investiga-
tional by many third-party payers. Endoscopy is not only a
mode of early detection (secondary prevention); it also
serves as primary prevention when a precancerous polyp is
removed. CRC screening is substantially underutilized in
the US, with only about 55% of those for whom screening
is recommended (persons 50 years and older) having been
screened with the recommended frequency [2].
Factors associated with the use of CRC screening may
be characterized as patient-related, physician-related, or
system-related. Patient-related factors include having in-
surance coverage, a source of medical care, and higher
education and income. A number of knowledge, belief,
and attitudinal factors also play an important role [3]. A
screening recommendation from a physician is the only
physician-related factor. System-related factors include
electronic medical records, ancillary personnel who can
provide follow-up and patient navigators [2]. African
Americans have by far the highest CRC incidence and mor-
tality rates of any racial/ethnic group. African American
mortality is 50% higher than the second-highest group
(white), and more than double that of the group with the
lowest mortality (Asian/Pacific Islander) [4]. Likely related
to the mortality disparity is the disparity in CRC screen-
ing. Similar percentages of African Americans (23.8%) and
whites (21.3%) age 50 years and older have had an FOBT
within the last two years, but whites (64.0%) are substan-
tially more likely to have had endoscopy (ever) than African
Americans (58.6%) (2008 data) [5].
Given the high mortality rate, the substantial racial
disparity and the reluctance of Americans (especially
African Americans) to be screened, the dissemination of
an evidence-based, low-cost intervention that would in-
crease screening is highly significant.
In 2010, we published the results of the CRC Screen-
ing Intervention Trial (CCSIT) [6] developed using
community-based participatory research principles [7].
We partnered with and received input from a community
coalition of advocates and agency staff. That coalition and
the Community Coalition Board of the Morehouse Pre-
vention Research Center (similar to a community advisory
board) also participated in carrying out the project, andthe latter group assisted in interpreting and disseminat-
ing results. This was a randomized controlled community
intervention trial in which three hundred and sixty-nine
African American men and women (aged ≥50) in the
Atlanta, GA metropolitan area were randomized to par-
ticipate in one of three interventions that had been chosen
to address evidence gaps in the Guide to Community Pre-
ventive Services [8]: one-on-one education, group educa-
tion, and reducing out-of-pocket costs. We compared the
three experimental cohorts to a control cohort. Following
the interventions, there were significant increases in know-
ledge about CRC in both educational cohorts but in nei-
ther the reduced out-of-pocket cost nor the control cohort.
By the six-month follow-up, 17.7% (11/6 of control group
members reported having undergone screening, as com-
pared to 33.9% (22/6 of the small group education (p =
0.039), 25.4% (17/6 of the one-on-one education (p = ns),
and 22.2% (14/6 of the reduced out-of-pocket cost groups
(p > 0.05).
The intervention included four one-hour sessions, each
consisting of a small group led by a health educator or
community health worker (facilitators). The presentations
and discussion covered CRC mortality data, signs and
symptoms, modifiable risk factors (e.g., dietary intake),
screening tests, and treatment approaches.
Subsequent to CCSIT, we entered into a partnership
with the local health department (Fulton County Depart-
ment of Health and Wellness) and local Office on Aging
to put EPICS into practice in the county’s 15 senior citi-
zen centers. At the urging of the health department’s
health educators, the number of sessions in the interven-
tion was shortened to three. In the practice demonstration,
331 mostly African-American men and women 50 years
and older who had never been screened for CRC, or who
were not up-to-date, received the intervention. At three-
month follow-up, 37.3% had been screened; another 33.8%
stated that they had appointments for screening or in-
tended to get an appointment [9]. It is unusual for an
intervention to perform as well in practice (effectiveness)
as in the research setting (efficacy). However, EPICS per-
formed at least as well in practice as it did in the commu-
nity intervention trial, even discounting participants who
had not yet been screened, but stated that they intended to
do so or had an appointment [9].
Based on initial success in a ‘real world’ setting, we
then initiated a state-wide EPICS dissemination and im-
plementation project. To reach most of the state, we
partnered with five of the six Regional Cancer Coalitions
of Georgia (RCCG) and their parent body, the Georgia
Cancer Coalition (GCC). We trained facilitators in each of
the regional coalitions and in 12 hospital-based American
College of Surgeon-accredited cancer programs. We also
gained firsthand knowledge of dissemination and imple-
mentation processes from the state practice demonstration
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egies for: engaging decision makers and stakeholders;
developing, packaging, and enhancing the intervention
toolkit; designing and improving facilitator training and
certification; developing an implementation protocol;
establishing quality assurance measures; and enhancing
technical assistance for successful efficacy-to-effectiveness
translation [10].
Goals and aims
The overall goals of this research are to identify the most
efficacious approach to disseminating EPICS and to iden-
tify the factors associated with its effectiveness.
Key aims are to:
1. Test passive and active approaches to disseminating
EPICS.
2. Measure the extent to which EPICS is accepted by
community coalitions and the fidelity of
implementation in various settings.
3. Estimate the potential for translation and the public
health impact of EPICS.
Methods/design
Ethical approval and informed consent
The Institutional Review Board (IRB) of the Morehouse
School of Medicine has approved our research plan. In-
formed consent will be obtained for all study partici-
pants: community coalition leaders, EPICS facilitators,
and individual participants. The study is registered with
ClinicalTrials.gov as NCT01805622.
Community coalitions
The community coalitions that will serve as clusters in
the EPICS cRCT are part of the National Black Leader-
ship Initiative on Cancer (NBLIC), a network that was
founded in 1987 and have primarily engaged in commu-
nity education efforts; this history has been described
elsewhere [11]. The coalitions include individuals from
academia, business, health care, non-profit organizations,
and other community stakeholders. Twenty of the 33
NBLIC community coalitions will be randomized as clus-
ters in the EPICS cRCT. In developing this project, we ex-
ecuted Memoranda of Understanding (MOU) between the
coalitions and Morehouse School of Medicine; recruited
research sites and surveyed the community coalitions’ or-
ganizational characteristics.
Trial design
This study is a four-arm, cluster randomized controlled
trial (cRCT). Figure 1 depicts information from four stages
of the EPICS cRCT (enrollment, intervention allocation,
follow-up, and analysis) based on the recommended flow
of parallel group randomized trials [12].Randomization at the organizational (community co-
alition) level has been chosen because this will minimize
contamination that may occur if individual participants
are randomized. In utilizing cluster randomization, we
will focus on community coalitions as the cluster for all
study arms, with individuals within their target settings
as the secondary unit. We will ensure balance in all four
study arms by ordering them into groups based on the
total number participating. A computer program gener-
ating random numbers between 1 and n will be used to
assign community coalitions to one of four conditions:
web access (WA) to facilitator training materials and
toolkits without technical assistance (TA); the same as 1,
but with technical assistance (TA); in-person access (IP)
to facilitator training materials and toolkits without TA;
and in-person access to facilitator training materials and
toolkits with TA. Our multilevel approach (e.g., cluster,
setting, and individual) promotes widespread dissemin-
ation [13]. Community coalitions will be allocated to
one of the four arms and informed consent will be ob-
tained from community coalition members and from in-
dividual participants.
Toolkit
The EPICS toolkit is a package that includes facilitator
training materials (manual, workshop agenda, and certifi-
cates); implementation protocol; EPICS curriculum; indi-
vidual/participant educational materials; and individual/
participant incentives. The toolkit was developed and pilot
tested during the local and state practice demonstrations.
Community coalitions randomized to passive dissemin-
ation arms will access all toolkit components except par-
ticipant incentives via the web. Those randomized to
active dissemination will receive all toolkit components via
in-person delivery. In the case of individual/participant in-
centives, delivery will be via US Postal Service for commu-
nity coalitions in all dissemination arms.
1. Facilitator training: Consistent with principles of
Adult Learning Theory, the EPICS facilitator training
workshop is skill-based, highly participatory, and
provides learners with immediate opportunities to
apply new skills and information [14]. A user-friendly
Facilitator Training Manual has been developed and
tested. The one-and-one-half-day facilitator training
workshop introduces basic vocabulary, concepts, and
methods of community-based cancer control and
instructional strategies for African Americans of
varying health literacy. Each community coalition will
identify a minimum of five members, in addition to a
leader, to complete facilitator training. Community
coalitions randomized to passive dissemination arms
will download training materials from the National










20 community coalitions 
randomized as clusters
Allocated to web access 
without technical 





clusters; potential 1,800 
participants)
Did not receive allocated 
intervention (n=0 
clusters; potential XX 
participants)
If not received allocated 
intervention, study group 
will give reasons
Allocated to in-person 
access with technical 





clusters; potential 1,800 
participants)
Did not receive allocated 
intervention (n=0 
clusters; potential XX 
participants)
If not received allocated 
intervention, study group 
will give reasons
Allocated to web access 
with technical assistance 




clusters; potential 1,800 
participants)
Did not receive allocated 
intervention (n=0 
clusters; potential XX 
participants)
If not received allocated 
intervention, study group 
will give reasons
Allocated to in-person 
access without technical 





clusters; potential 1,800 
participants)
Did not receive allocated 
intervention (n=0 
clusters; potential XX 
participants)
If not received allocated 
intervention, study group 
will give reasons
Lost to follow-up (n=0 
clusters; n=0 participants 
in EPICS sessions; 
potential XX participants 




clusters; potential XX 
participants) If 
discontinued, study group 
will give reasons
Lost to follow-up (n=0 
clusters; n=0 participants 
in EPICS sessions; 
potential XX participants 




clusters; potential XX 
participants) If 
discontinued, study group 
will give reasons
Lost to follow-up (n=0 
clusters; n=0 participants 
in EPICS sessions; 
potential XX participants 




clusters; potential XX 
participants) If 
discontinued, study group 
will give reasons
Lost to follow-up (n=0 
clusters; n=0 participants 
in EPICS sessions; 
potential XX participants 




clusters; potential XX 
participants) If 
discontinued, study group 
will give reasons
Analyzed (n=5 clusters; 
potential XX 
participants)
Excluded from analysis 
(n=0 clusters; potential 
XX participants) If 
excluded, study group 
will give reasons
Analyzed (n=5 clusters; 
potential XX 
participants)
Excluded from analysis 
(n=0 clusters; potential 
XX participants) If 
excluded, study group 
will give reasons
Analyzed (n=5 clusters; 
potential XX 
participants)
Excluded from analysis 
(n=0 clusters; potential 
XX participants) If 
excluded, study group 
will give reasons
Analyzed (n=5 clusters; 
potential XX 
participants)
Excluded from analysis 
(n=0 clusters; potential 
XX participants) If 
excluded, study group 
will give reasons
Figure 1 CONSORT flow diagram for EPICS cRCT.
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index.do) and conduct the training themselves, while
those in active dissemination arms will be trained by
EPICS developers. The facilitator training workshopconsists of three modules that address: principles
knowledge (e.g., conceptual framework, intervention
overview, and local/statewide demonstration projects);
procedural knowledge (e.g., how to implement the
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(e.g., how to market the programs and complete the
EPICS assessments and measures).
2. Implementation Protocol: We also developed and
tested a protocol similar to that used in the original
CCSIT study and converted it into non-academic
language. This 12-step protocol includes procedures
to: recruit community partners; schedule sessions;
market the program; recruit participants; prepare for
the sessions; sort the toolkit; assign facilitators;
deliver the sessions; identify ‘completers’
(participants attending all three intervention
sessions); monitor screening; submit reports; and get
technical assistance.
3. EPICS Curriculum: Individual participants in all
study arms will complete three small group
educational sessions. These sessions, each
approximately one-hour in length, will be conducted
the same day/time of the week for three consecutive
weeks. This schedule will be formulated by NBLIC
community coalitions in conversation with
intervention settings at a time likely to solicit the
greatest participation.
4. Individual/participant CRC educational materials
include three session-specific brochures, CDC
consumer education materials, including: Get Smart
in Your Family Dinner; Get Smart as You Shop; and
CRC Facts on Screening.
5. Individual/participant incentives such as a cookbook,
water bottles, shopping bag, and similar items are
distributed to individuals completing all three EPICS
sessions.
Churches, clinical partners, and community sites
Three settings with congregants, patients or clients, aged
50 to 74 years, will participate in the study: churches,
including Protestant and Catholic churches and other
faith-based institutions; clinical cites, including health
departments, community health centers, hospitals and
similar healthcare providers; and community cites, includ-
ing senior citizen centers, assisted living facilities, and
community centers. NBLIC community coalitions, based
on their relationship and history with these community
institutions, will work closely with the leaders of these or-
ganizations to assist in individual participant recruitment.
Individual participants
English-speaking, African Americans, 50 to 74 years of
age, who are not current on CRC screening, are eligible
for study participation. Individuals with a personal his-
tory of CRC or inflammatory bowel disease, blindness or
severe hearing impairment; dementia; or other condition
with life expectancy less than two years, are ineligible for
participation.Sample size calculation
We intend to enroll 7,200 individuals in this study, with
1,800 enrolled in each study arm. This sample size is
based on 20 NBLIC community coalitions randomized to
four study arms (WA, WA+TA, IP, IP + TA). There will
also be three settings (church, clinic, and community site)
per coalition. Each community coalition will have 30 groups
of individuals completing three consecutive EPICS sessions,
recruiting 15 individuals per setting with an expected 25%
dropout rate; thus, we anticipate that 12 of these individuals
will complete all three sessions. For the EPICS cRCT, there
will be (30 groups of three sessions) × (12 individuals com-
pleting all three sessions) × (20 NBLIC community coali-
tions) = 7,200 individuals. Based on data from a previously
published study, we calculated intracluster correlation coef-
ficient (ICC) to equal 0.0911 (9.1%) [6]. The effective sam-
ple size (ESS) was 5,645, which still has high power (>99%)
with design effect of 1.2754.
Hypotheses
We propose three hypotheses to measure the impact of
our effort:
Hypothesis one (H1): When compared to passive
dissemination, active dissemination will result in
greater participant enrollment.
Hypothesis two (H2): The intervention will be offered
with equal fidelity in churches, clinics, and community
sites.
Hypothesis three (H3): Knowledge of CRC screening
and perceived risk of CRC will be positively correlated.
Power analysis
Power calculations were performed to further justify our
proposed sample size. All of these assume a sample size of
1,800 per study arm, a significance level of 5% (i.e. alpha =
0.05), and a two-sided two-group chi-square test of pro-
portions. Calculations were performed using nQuery Ad-
visor, version 7. These are performed for hypothesis one
(H1) and hypothesis three (H3); hypothesis two (H2) is
qualitative, so power calculations do not apply. For H1, we
anticipate that there will be 25%, 33%, and 50% greater
participant enrollment with the Web + TA arm, IP arm,
and IP + TA arm, respectively, when compared to the pas-
sive web-based-only arm (based on our prior experience
with community coalition based studies). Comparisons
of any of these proportions to any proportion that is
obtained for the passive web-based arm (for example, 5%,
10%, or 20%) will result in greater than 99% power to de-
tect differences in the proportions as being statistically
significant. For H3, we can obtain estimates of cancer
knowledge change over time (pre-intervention to post-
intervention percentages with the correct response) for a
small group education cohort and a control cohort from
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changes of 34.8 (71-36) and 15.5 (55.2-39) for a CRC
perceived risk question, and 22.9 (92.9–70) and 13.1
(88.5–75.for a CRC screening question. Assuming that we
observe similar changes in our study participants for active
and passive arms, we will have greater than 99% power to
detect differences in the proportions as being statistically
significant.Theoretical framework
We will use Rogers’ Diffusion of Innovation Theory and
Glasgow’s RE-AIM (Reach, Effectiveness, Adoption, Im-
plementation, Maintenance) evaluation framework to
guide the EPICS cRCT (Figure 2).
Based on Rogers’ theory, innovations that are simple,
such as EPICS, are often adopted more rapidly and lead
to a higher degree of sustainability. Diffusion of Innova-
tions Theory addresses the process of adoption and up-
take of interventions by a targeted audience. Three key
components of this theory make it well-suited to facili-
tate adoption of EPICS at the cluster and setting levels.
Research suggests that the most effective communication




















Figure 2 Study overview.social support theory, which uses informal communication
channels, helped explain the success of EPICS.
We will continue to use informal communication chan-
nels (as recommended by Rogers) to reach change agents
and early adopters. Change agents are organizations con-
nected to early adopters, organizations that will attempt
EPICS before other organizations [15]. Rogers’ theory will
provide valuable insights into why EPICS is adopted by
some NBLIC community coalitions and not by others. In
the EPICS cRCT, this theory will:
1. Explain variance in adoption rates: All clusters will
complete Barriers and Enablers to Uptake
Assessment (which include setting level-specific
questions) to measure key attributes.
2. Explore the impact of facilitators on EPICS
dissemination: We will compare key attributes and
facilitator knowledge, attitudes and confidence
(Pre and Post-Facilitator Training Knowledge,
Attitudes and Confidence survey).
3. Evaluate fidelity of implementation to determine
adherence to EPICS core elements.
4. Examine the relationship between adoption and
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completing all three EPICS sessions).
5. Establish the role of TA: Comparing passive
and active arms (providing reinforcement
and positive feedback in Rogers’ confirmation
stage).
RE-AIM is a framework developed by Glasgow et al.
designed to evaluate interventions that change health
behavior [16]. It has been applied to dissemination stud-
ies of various behavioral modification interventions, in-
cluding a smokeless tobacco intervention [17], diabetes
self-management programs [18], smoking cessation [19],
physical activity [20], and worksite health behavior inter-
ventions [21], as well as interventions in churches [22]
and schools [23]. The RE-AIM model is intended to re-
focus priorities on public health issues and provide bal-
anced emphasis on internal and external validity. Glasgow
also concluded that simple and flexible interventions that
can be implemented by non-researchers have the greatest
potential for long-term maintenance.
RE-AIM is a good tool for evaluating the dissemin-
ation of interventions like EPICS, which have the poten-
tial to reach a large audience, can be broadly adopted,
and can be implemented by different types of staff with-
out a heavy investment of resources [16].
Primary outcome measures
The primary outcome for the EPICS cRCT focuses on
the Reach and Effectiveness components of the RE-
AIM (Reach, Effectiveness, Approach, Implementation,
Maintenance) model. Reach refers to the proportion of
representative eligible organizations, settings, and indi-
viduals participating in the intervention. To determine
EPICS Reach, we will examine two dimensions of this
concept, estimated based on the following calculation
[24]:
Number of participants in
Estimate of REACH
¼ the target population who receive the three EPICS sessions  100
Number of eligible participants in the target settings
In the RE-AIM framework, effectiveness is the impact
of the intervention on desired outcomes. For the EPICS
cRCT, CRC screening adherence will be based on baseline
community CRC screening rates from the Centers for Dis-
ease Control and Prevention’s (CDC) Behavioral Risk Factor
Surveillance System (BRFSS), post intervention participant
self-reported FOBT, flexible sigmoidoscopy and/or colonos-
copy, and changes in facilitators’ CRC knowledge, attitudes,
and beliefs. Adherence to CRC screening on a total popula-
tion basis is calculated as:Number of participants
Adherence to CRC screening
¼ adherent to CRC screening in the population
Estimated target population by setting
In alignment with Glasgow’s RE-AIM definition, our es-
timate of effectiveness will be determined using the fol-
lowing formula [24]:
Number of participants in the sample of the target
population
Estimate of Effectiveness
¼ who were Reached and adherent to CRC screening
Number of participants in the target population who were reached
To determine the effectiveness of this dissemination
study, we will examine changes in CRC screening ad-
herence rates, based on the pre-intervention and post-
intervention in each NBLIC community coalition targeted
community. Use of individual outcome measures in evalu-
ating group-level interventions is valid and widely used
with an appropriate analysis framework. Our analysis will
be based on the principle of intention-to-treat and use the
Generalized Estimating Equation (GEE) for modeling the
CRC screening adherence in all African Americans, ages 50
to 74 years in the targeted communities pre-intervention
and post-intervention. Specifically, the model for the ith
community’s jth time point’s kth participant’s adherence sta-
tus Yijk will take the form: logit Pr[Yijk = Adherent] = β0 + β1
I{i = community} + β2 I{j = Post-intervention} + β3 I{i = community I{j =
Post-intervention} + γ
T X where I{A} is an indicator variable for
a set A, X is a vector of covariates to be adjusted for, and
β’s and γ (a vector communities, in the change in log odds
of the CRC screening adherence from pre-intervention to
post-intervention. Our statistical inference on β3 will be
based on the asymptotic robust inference procedure of the
GEE method. Special caution will be exercised in the inclu-
sion of covariates X into the model and the interpretation
of the results, as our study design is a cluster randomized
controlled trial.
Secondary outcome measures
Qualitative and quantitative research methods are useful
in gaining insight and understanding of human behavior,
and are recommended by Rogers to study the process of
an innovation’s adoption. The secondary outcome for
the EPICS cRCT is the percentage of clusters and set-
tings implementing the EPICS sessions. In the RE-AIM
framework, adoption is concerned with the representa-
tiveness of both the setting in which an intervention is
conducted and the change agents who deliver the inter-
vention. EPICS implementation is concerned with qual-
ity and consistency of the intervention delivery. It refers
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vention are delivered as intended in real-world settings.
The final RE-AIM dimension, maintenance, refers to
the extent to which a program or policy becomes insti-
tutionalized or part of the routine organizational practices
and policies. At the individual level, measuring mainten-
ance requires follow-up contact six-months or more
post-intervention. Due to the timing of CRC screening
recommendations (e.g., one to ten years), we will not meas-
ure individual maintenance, but will focus at the change
agent or cluster level, measuring long-term institutional
effects. Organizational impact will be measured based on
the following calculation, where fidelity is scored 1 to 4
according to the core elements listed in Table 1:
Estimate of Impact
¼ % clusters adopting x % implementing x % institutionalizing EPICS
fidelity to core elements
Adoption is the percent of NBLIC community coalitions
approached for participation who did, in fact, participate.
Adjustments for attrition will be made using intent-to-treat
analysis. Implementation is the average percent and extent
to which core elements are implemented as intended. In-
stitutionalization is the extent to which NBLIC community
coalitions continue to offer EPICS post-implementation.
Cost-effectiveness analysis
The active dissemination strategies used in this project
are expected to be more effective in engaging the com-
munity to implement EPICS with fidelity and thus more
effective in increasing CRC screening rates. However, they
will also be more expensive than the passive strategies of
dissemination. Therefore, in a cost-effectiveness analysis
we will determine whether the increased cost is worth the
increased effectiveness. We will compare costs and out-
comes of the WA, WA + TA, IP, IP + TA dissemination
strategies. The cost-effectiveness analysis will be done from
the perspective of a public health agency interested in dis-
seminating EPICS (disseminator). It will thus include costs
and benefits of disseminator, community coalitions, and
settings. Effectiveness will be measured as described above
by the increased adherence to CRC screening. Costs of theTable 1 EPICS sessions
# Title
1 Introduction to EPICS This session pro
Definitions and
sigmoidoscopy






3 Maintaining healthy habits This session enco
into their lifestyle
these healthier lifdissemination strategies will be collected using the assess-
ment tools described above, plus study records and time
logs (for example for costs of web and IP training time
of personnel and materials, marketing materials, TA per-
sonnel time and expenses). From the NBLIC community
coalitions we will collect data on costs incurred to engage
community partners. Moreover, via periodic telephone in-
terviews to assess the adherence to EPICS implementation
protocol we will also collect information on costs related
to recruiting participants and delivering the intervention.
Costs of personnel time will be valued using age and gen-
der specific wages as reported by the Bureau of Labor Sta-
tistics. Costs and outcomes occurring in year two will be
discounted using a 3% discount rate. Costs and outcomes
of each dissemination strategy will be compared to first
eliminate dominated strategies, i.e., those that are more
costly than the next most effective ones. Among those
that are not dominated we will calculate Incremental
Cost Effectiveness Ratios (ICERs), i.e., the ratio of the
costs of each strategy net of those of the next less
effective one, by the effectiveness. ICERs will be com-
pared to those of similar interventions to establish cost-
effectiveness. In addition, we will obtain measures of
efficiency for each strategy, i.e., cost per person screened,
cost per community partner engaged, and other similar
measures. In sensitivity analyses we will vary inputs of the
analysis such as wages of personnel or number of partici-
pants per education session, to provide a range of cost-
effectiveness values under different assumptions.
Methods and statistical analysis
Statistical analysis will be completed based on the RE-AIM
(Reach, Effectiveness, Adoption, Implementation, Main-
tenance) framework based on methods as outlined below.
Reach
Methods determining EPICS’s reach included: establishing
inclusion criteria and documenting exclusions, participa-
tion rates, dropouts and representativeness; assessing size
and characteristics of NBLIC community coalitions and
church, clinical and community settings to determine
barriers to participation (e.g., infrastructure, time,Content
vides a general overview of colorectal cancer (CRC) facts.
screening guidelines; fecal occult blood test (FOBT),
and colonoscopy; costs; insurance coverage
oms explained. Finding the cause of symptoms through CEA assay,
gmoidoscopy or colonoscopy. Definition of treatment methods
therapy, radiation therapy, biological therapy) Clinical Trials; Social
ing a plan; monitoring success; EPICS colorectal cancer screening goals.
urages participants to incorporate healthier cooking and eating habits
s. It also focuses on CRC screening as an important health habit. Incorporating
estyles may potentially confound the effect of the intervention on CRC use.
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ticipants (African American, age 50 to 74, either gender)
per setting consenting participation; documenting the
number of community coalitions by characteristics; de-
scription of settings (total number of eligible partici-
pants); and estimating the number of eligible individuals
and completers of EPICS sessions per setting. Propor-
tion of eligible community coalitions and settings aware
of EPICS will be calculated and two-group t tests and
chi-square tests to compare those aware versus not aware
will be completed. Analysis of variance will compare the
degree of change in EPICS awareness among leaders of
community coalitions and settings and the increase in
post intervention CRC screening knowledge scores will be
determined using a paired t test.
Effectiveness
To determine effectiveness, investigators will: compare
CRC screening rates of passive and active dissemination ap-
proaches by setting; examine baseline/post CRC screening
rates (community coalition catchment area) and compare
baseline/post CRC knowledge attitudes; and beliefs of facili-
tators (training) and participants (EPICS sessions). Effect
size will be computed by subtracting mean CRC screening
rates in communities aware and not aware of EPICS di-
vided by the pooled standard deviation of CRC screening
rates. The proportion of community coalitions and settings
aware of EPICS (effectiveness-organizational level) and that
deliver it (adoption) will also be determined.
Adoption
In evaluating adoption, methods include: determining
EPICS fit, cost, level of resources and expertise and simi-
larity to current programs; estimating adoption rate (pro-
portion of community coalitions trained that implement
EPICS); and documenting reasons for not adopting EPICS
(time, total membership or infrastructure, partnerships,
program priorities). Descriptive statistics will be used to
provide insight into organizational and individual reasons
for (not) adopting EPICS. Differences between community
coalitions adopting and not adopting EPICS and differ-
ences between facilitator characteristics will be analyzed
using independent sample t tests and chi-square tests.
Implementation
To evaluate EPICS implementation, the following methods
will be employed: train and certify facilitators to deliver
educational sessions; implement marketing strategies to
enhance visibility; provide on-going technical assistance
(TA) to organizations and settings; determine adherence to
implementation protocol by passive and active dissemin-
ation sites; estimate total number of completers; conduct
one-and-one-half day training guided by three modules:
principles, procedural and practical knowledge; distribute amonthly newsletter, provide promotional flyers and posters
to community coalitions and settings; conduct one-hour
monthly teleconferences; assess the nature and quality of
TA; measure level of fidelity to delivering sessions as devel-
oped; and determine total number of individuals complet-
ing the three educational intervention sessions. Descriptive
statistics will determine differences in facilitator character-
istics, knowledge, attitudes, and beliefs and level of satisfac-
tion with training, the most effective marketing strategies,
reasons for not implementing components, duration, and
investment and differences facilitator demographic char-
acteristics: education, gender, profession, insurance status,
etc. Logistic regression analysis will evaluate variations in
the effects of implementation barriers among community
coalitions, settings and individual participants.
Maintenance
To evaluate the final construct in the RE-AIM framework,
the following methods will be completed: determine per-
cent of community coalitions indicating that EPICS will
become standard practice; measure program feasibility, in-
cluding cost, time, and human resources for program im-
plementation; determine if EPICS facilitator training and
curriculum is offered to additional settings; investigate the
extent to which EPICS is integrated into community coali-
tion planned activities; measure enablers and barriers to
continued EPICS implementation and plans to continue or
‘intent’ to offer; determine number of clusters and settings
who had once offered EPICS but stopped; and determine
the extent to which churches, clinical providers and com-
munity sites continue EPICS sessions post-implementation.
Logistic regression analysis will evaluate variations in the
effects of implementation barriers among community coali-
tions and settings. Descriptive statistics will determine set-
ting by type and number completing facilitator training.
Trial timeframe
The EPICS cRCT is planned from May 2012 until March
2017. In months one to three, the EPICS Coordinating
Center will be established and monthly teleconferences, be-
tween the MSM research team and NBLIC community
coalitions, will take place. Community coalitions will be
randomized into four study arms. Recruitment of commu-
nity settings (e.g., churches, clinics, and community sites)
and potential facilitators by community coalitions and base-
line CRC screening rates for each targeted community will
also be completed during this time. From months four to
seven, facilitator training/certification will be completed,
followed by a four-month pilot period (months eight to
twelve). The implementation phase, months 13 to 36, in-
cludes delivery of three educational sessions and follow-up
to determine CRC screening status of 7,200 African Ameri-
cans in 13 US states to evaluate EPICS adoption and effect-
iveness. The final 18 months of the active study (months
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The final six months (54–60) will be reserved for data ana-
lysis, publications, and reporting.
Trial status
The EPICS cRCT completed its pilot phase February 28,
2013. The Implementation Phase will begin May 1, 2013.
Discussion
Implementing EPICS in partnership with community coa-
litions, we hypothesized, will result in more rapid adoption
than traditional top-down approaches, and that changes in
community CRC screening practices are more likely to be
sustainable over time. With its national reach, this study
has the potential to enhance our understanding of barriers
and enablers to the uptake of educational programs aimed
at eliminating cancer health disparities.
Glasgow et al. at the National Institutes of Health (NIH)
have stated: ‘there is a need for research testing ap-
proaches to scaling up and sustaining effective interven-
tions’ [25]. This project will help address that need and
will focus on the five core values cited by Glasgow et al.:
rigor and relevance, efficiency, collaboration, improved
capacity, and cumulative knowledge. Regarding the first,
the project will utilize the rigorous research methods re-
quired of NIH-funded studies; but of equal importance, it
will test dissemination in settings that are similar to those
in communities across the country, where they often serve
African Americans. The project is efficient in that it tests
several settings simultaneously. It involves widespread col-
laboration through its reliance on community coalitions
that are comprised of healthcare professionals, business
people, lay advocates, cancer survivors, and others. The
project is building improved capacity in these coalitions;
as a consequence, they will be prepared to participate in
other cancer prevention studies in the future. The project
is the product of cumulative knowledge developed through
the original community intervention trial, the local practice
demonstration, and the statewide initiative. These multiple
iterations made possible the current study. The current
study should be the last iteration; at its conclusion, EPICS
will be positioned to become a part of standard health pro-
motion practice.
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